Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Oncol
Huvudupphovsmän: D'Aniello, Carmine, Berretta, Massimiliano, Cavaliere, Carla, Rossetti, Sabrina, Facchini, Bianca Arianna, Iovane, Gelsomina, Mollo, Giovanna, Capasso, Mariagrazia, Pepa, Chiara Della, Pesce, Laura, D'Errico, Davide, Buonerba, Carlo, Di Lorenzo, Giuseppe, Pisconti, Salvatore, De Vita, Ferdinando, Facchini, Gaetano
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2019
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://ncbi.nlm.nih.gov/pubmed/31921657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01400
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk